Unknown

Dataset Information

0

BubR1 is modified by sumoylation during mitotic progression.


ABSTRACT: BubR1 functions as a crucial component that monitors proper chromosome congression and mitotic timing during cell division. We investigated molecular regulation of BubR1 and found that BubR1 was modified by an unknown post-translation mechanism during the cell cycle, resulting in a significant mobility shift on denaturing gels. We termed it BubR1-M as the nature of modification was not characterized. Extended (>24 h) treatment of HeLa cells with a microtubule disrupting agent including nocodazole and taxol or release of mitotic shake-off cells into fresh medium induced BubR1-M. BubR1-M was derived from neither phosphorylation nor acetylation. Ectopic expression coupled with pulling down analyses showed that BubR1-M was derived from SUMO modification. Mutation analysis revealed that lysine 250 was a crucial site for sumoylation. Significantly, compared with the wild-type control, ectopic expression of a sumoylation-deficient mutant of BubR1 induced chromosomal missegregation and mitotic delay. Combined, our study identifies a new type of post-translational modification that is essential for BubR1 function during mitosis.

SUBMITTER: Yang F 

PROVIDER: S-EPMC3281637 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

BubR1 is modified by sumoylation during mitotic progression.

Yang Feikun F   Hu Liyan L   Chen Cheng C   Yu Jianxiu J   O'Connell Christopher B CB   Khodjakov Alexey A   Pagano Michele M   Dai Wei W  

The Journal of biological chemistry 20111213 7


BubR1 functions as a crucial component that monitors proper chromosome congression and mitotic timing during cell division. We investigated molecular regulation of BubR1 and found that BubR1 was modified by an unknown post-translation mechanism during the cell cycle, resulting in a significant mobility shift on denaturing gels. We termed it BubR1-M as the nature of modification was not characterized. Extended (>24 h) treatment of HeLa cells with a microtubule disrupting agent including nocodazol  ...[more]

Similar Datasets

| S-EPMC4210015 | biostudies-literature
| S-EPMC4987139 | biostudies-literature
| S-EPMC3318109 | biostudies-literature
2024-10-31 | MSV000096264 | MassIVE
| S-EPMC4096495 | biostudies-literature
| S-EPMC6879332 | biostudies-literature
| S-EPMC5796985 | biostudies-literature
| S-EPMC8641411 | biostudies-literature
| S-EPMC2582891 | biostudies-other
| S-EPMC5458268 | biostudies-other